{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T11:12:36Z","timestamp":1773054756434,"version":"3.50.1"},"reference-count":31,"publisher":"Royal College of Psychiatrists","issue":"2","license":[{"start":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T00:00:00Z","timestamp":1517184000000},"content-version":"unspecified","delay-in-days":12050,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Psychiatry"],"published-print":{"date-parts":[[1985,2]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Fifteen patients with bulimia nervosa received fenfluramine (60 mg po) or placebo under double-blind, randomly ordered conditions. Two hours later food was presented. Significantly less food was eaten after fenfluramine and the quantity eaten was inversely correlated with serum fenfluramine levels. Significantly fewer patients reported bulimic symptoms during the test after fenfluramine, but no significant effect was demonstrated after leaving the ward. Fenfluramine caused drowsiness but did not reduce hunger ratings. Similarly, eating failed to reduce hunger ratings normally in the patients. These findings suggest that in patients with bulimia nervosa, hunger is reported abnormally and eating is suppressed by fenfluramine. Bulimic symptoms were probably reduced by fenfluramine, which may prove to be a useful treatment for bulimia nervosa.<\/jats:p>","DOI":"10.1192\/bjp.146.2.169","type":"journal-article","created":{"date-parts":[[2008,8,12]],"date-time":"2008-08-12T19:20:52Z","timestamp":1218568852000},"page":"169-176","source":"Crossref","is-referenced-by-count":68,"title":["Suppression of Eating by Fenfluramine in Patients with Bulimia Nervosa"],"prefix":"10.1192","volume":"146","author":[{"given":"P. H.","family":"Robinson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. A.","family":"Checkley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. F. M.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"170","published-online":{"date-parts":[[2018,1,29]]},"reference":[{"key":"S0007125000120525_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-0070(83)80222-8"},{"key":"S0007125000120525_ref4","first-page":"465P","article-title":"Plasma concentrations of fenfluramine and its metabolite, norfenfluramine, after single and repeated oral administration","volume":"43","author":"Campbell","year":"1971","journal-title":"British Journal of Pharmacology"},{"key":"S0007125000120525_ref8","unstructured":"Documenta Geigy (1959) Scientific Tables, 7th Edition. (Eds. Diem K. and Lentner C. )."},{"key":"S0007125000120525_ref16","volume-title":"Statistics for the Social Sciences","author":"Hays","year":"1973"},{"key":"S0007125000120525_ref9","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700041209"},{"key":"S0007125000120525_ref31","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1176\/ajp.134.11.1249","article-title":"Phenytoin treatment of the binge eating syndrome","volume":"134","author":"Wermuth","year":"1977","journal-title":"American Journal of Psychiatry"},{"key":"S0007125000120525_ref18","doi-asserted-by":"publisher","DOI":"10.1185\/03007997909117505"},{"key":"S0007125000120525_ref25","first-page":"171","article-title":"The anorectic activity of fenfluramine","volume":"51","author":"Silverstone","year":"1975","journal-title":"Postgraduate Medical Journal"},{"key":"S0007125000120525_ref27","doi-asserted-by":"publisher","DOI":"10.1007\/BF01575455"},{"key":"S0007125000120525_ref22","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700004323"},{"key":"S0007125000120525_ref10","volume-title":"Smith, Kline and French Publications","volume":"1","author":"Fairburn","year":"1982"},{"key":"S0007125000120525_ref3","doi-asserted-by":"publisher","DOI":"10.1185\/03007997909117490"},{"key":"S0007125000120525_ref6","volume-title":"Mayler's Side Effects of Drugs","author":"Connell","year":"1975"},{"key":"S0007125000120525_ref1","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1980"},{"key":"S0007125000120525_ref5","volume-title":"Maudsley Monograph","author":"Connell","year":"1958"},{"key":"S0007125000120525_ref7","doi-asserted-by":"publisher","DOI":"10.1185\/03007997909117502"},{"key":"S0007125000120525_ref11","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700042999"},{"key":"S0007125000120525_ref14","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1176\/ajp.1974.131.4.428","article-title":"Treatment of compulsive eating disturbances with anticonvulsant medication","volume":"131","author":"Green","year":"1974","journal-title":"American Journal of Psychiatry"},{"key":"S0007125000120525_ref12","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1980.01780220074008"},{"key":"S0007125000120525_ref13","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700030762"},{"key":"S0007125000120525_ref15","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.23.1.56"},{"key":"S0007125000120525_ref17","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(79)90166-7"},{"key":"S0007125000120525_ref19","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.143.3.288"},{"key":"S0007125000120525_ref20","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1176\/ajp.140.5.554","article-title":"Bulimia treated with imipramine: a placebo controlled, double blind study","volume":"140","author":"Pope","year":"1983","journal-title":"American Journal of Psychiatry"},{"key":"S0007125000120525_ref23","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700031974"},{"key":"S0007125000120525_ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1983.tb05866.x"},{"key":"S0007125000120525_ref26","volume-title":"Central Mechanisms of Anorectic Drugs","author":"Silverstone","year":"1978"},{"key":"S0007125000120525_ref21","doi-asserted-by":"publisher","DOI":"10.1097\/00006842-198308000-00003"},{"key":"S0007125000120525_ref28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(73)90325-5"},{"key":"S0007125000120525_ref29","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1176\/ajp.139.12.1629","article-title":"Treatment of bulimia with monoamine oxidase inhibitors","volume":"139","author":"Walsh","year":"1982","journal-title":"American Journal of Psychiatry"},{"key":"S0007125000120525_ref30","first-page":"201","article-title":"Dietary restraint and binge eating","volume":"4","author":"Wardle","year":"1980","journal-title":"Behavioural Analysis and Modification"}],"container-title":["British Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0007125000120525","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T12:31:39Z","timestamp":1588854699000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0007125000120525\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1985,2]]}},"alternative-id":["S0007125000120525"],"URL":"https:\/\/doi.org\/10.1192\/bjp.146.2.169","relation":{},"ISSN":["0007-1250","1472-1465"],"issn-type":[{"value":"0007-1250","type":"print"},{"value":"1472-1465","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,2]]}}}